Attached files
| file | filename |
|---|---|
| 10-K/A - FORM 10-K/A - PLUS THERAPEUTICS, INC. | form10ka.htm |
| EX-31.1 - EXHIBIT 31.1 - PLUS THERAPEUTICS, INC. | ex31_1.htm |
| EX-31.2 - EXHIBIT 31.2 - PLUS THERAPEUTICS, INC. | ex31_2.htm |
EXHIBIT 32.1
CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350/ SECURITIES EXCHANGE ACT RULE 13a-14(b), AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES – OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Cytori Therapeutics, Inc. for the year ended December 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report") Marc H. Hedrick, as President & Chief Executive Officer of Cytori Therapeutics, Inc., and Tiago Girão, as VP of Finance and Chief Financial Officer of Cytori Therapeutics, Inc., each hereby certifies, respectively, that:
|
1.
|
The Report that this certification accompanies fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934.
|
|
2.
|
The information contained in the Report that this certification accompanies fairly presents, in all material respects, the financial condition and results of operations of Cytori Therapeutics, Inc.
|
|
By:
|
/s/ Marc H. Hedrick, MD
|
|
|
Dated: March 24, 2016
|
Marc H. Hedrick, MD
|
|
|
President & Chief Executive Officer
|
||
|
By:
|
/s/ Tiago M. Girão
|
|
|
Dated: March 24, 2016
|
Tiago M. Girão
|
|
|
VP of Finance and Chief Financial Officer
|